Cargando…

Opioid-Induced Constipation: Cost Impact of Approved Medications in the Emergency Department

INTRODUCTION: Opioid-induced constipation (OIC) prescription medications (OIC-Rx) like methylnaltrexone subcutaneous (SC) have shown efficacy in treating OIC in the emergency department (ED). This study aimed to describe and compare healthcare resource utilization (HRU) and healthcare costs in ED pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peacock, W. Frank, Slatkin, Neal, Gagnon-Sanschagrin, Patrick, Maitland, Jessica, Guérin, Annie, Joseph, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056463/ https://www.ncbi.nlm.nih.gov/pubmed/35298784 http://dx.doi.org/10.1007/s12325-022-02090-9

Ejemplares similares

The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation
por: Liao, Solomon S., et al.
Publicado: (2021)

Correction to: The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation
por: Liao, Solomon S., et al.
Publicado: (2021)

Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain
por: Rauck, Richard L, et al.
Publicado: (2018)

Treatment Patterns Among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims Analysis
por: Schein, Jeff, et al.
Publicado: (2023)

Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose
por: Chamberlain, Bruce H, et al.
Publicado: (2023)

Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation
por: Farchadi, David, et al.
Publicado: (2023)

Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness
por: Mehta, Neel, et al.
Publicado: (2023)

Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials
por: Mehta, Neel, et al.
Publicado: (2023)

Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States – a retrospective claims analysis
por: Schein, Jeff, et al.
Publicado: (2022)

Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspective
por: Hariprasad, Seenu M, et al.
Publicado: (2021)

Assessment of costs associated with adverse events in patients with cancer
por: Wong, William, et al.
Publicado: (2018)

Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies
por: Chamberlain, Bruce H, et al.
Publicado: (2021)

Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019)

Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials
por: Shah, Eric D, et al.
Publicado: (2023)

The burden of pediatric emergency departments, constipation: a systematic review
por: Kaçer, Emine Özdemir, et al.
Publicado: (2022)

Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation
por: Chokhavatia, Sita, et al.
Publicado: (2016)

Methylnaltrexone in the treatment of opioid-induced constipation
por: Meerveld, Beverley Greenwood-Van, et al.
Publicado: (2008)

Impact of agitation in long‐term care residents with dementia in the United States
por: Fillit, Howard, et al.
Publicado: (2021)

Identifying individuals with undiagnosed post-traumatic stress disorder in a large United States civilian population – a machine learning approach
por: Gagnon-Sanschagrin, Patrick, et al.
Publicado: (2022)

Abdominal Pain due to Opioid-Induced Constipation
por: Jacobs, Chelsea, et al.
Publicado: (2019)

Opioid-Induced Constipation in Advanced Cancer Patients
por: ALMouaalamy, Nabil
Publicado: (2021)

Change to costs and lengths of stay in the emergency department and the Brisbane protocol: an observational study
por: Cheng, Qinglu, et al.
Publicado: (2016)

The impact of constipation on pediatric emergency department: a retrospective analysis of the diagnosis and management.
por: Gatto, Antonio, et al.
Publicado: (2021)

Time on shift in the emergency department and decision to prescribe opioids to patients without chronic opioid use
por: Agarwal, Isha, et al.
Publicado: (2022)

Identification and Treatment of Opioid Withdrawal and Opioid Use Disorder in the Emergency Department
por: Jennings, Lindsey, et al.
Publicado: (2020)

Impact of opioid-induced constipation on opioid substitution therapy management: the patient perspective
por: Lugoboni, Fabio, et al.
Publicado: (2021)

The Changing Use of Intravenous Opioids in an Emergency Department
por: Sutter, Mark E., et al.
Publicado: (2015)

Editorial: Optimizing opioid prescriptions in the emergency department
por: Dahaba, Ashraf A., et al.
Publicado: (2023)

Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management
por: Kumar, Lalit, et al.
Publicado: (2014)

Clinical utility of naloxegol in the treatment of opioid-induced constipation
por: Bruner, Heather C, et al.
Publicado: (2015)

Management pathway for emergency department patients in the setting of the opioid epidemic and emergency department overcrowding
por: Gurley, Kiersten, et al.
Publicado: (2020)

Evidence-based Standardization of Constipation Management in the Emergency Department: A Quality Improvement Study
por: Lipshaw, Matthew J., et al.
Publicado: (2021)

Treatment of Severe Pain and Opioid-induced Constipation: An Observational Study of Quality of Life, Resource Use, and Costs in Sweden
por: Hjalte, Frida, et al.
Publicado: (2016)

Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery
por: Wittbrodt, Eric T, et al.
Publicado: (2018)

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
por: Pergolizzi Jr, Joseph V, et al.
Publicado: (2020)

Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation
por: Dik, Vincent K., et al.
Publicado: (2014)

Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019)

Prescribing Patterns for Outpatient Treatment of Constipation, Irritable Bowel Syndrome-Related Constipation, and Opioid-Induced Constipation: A Retrospective Cross-Sectional Study
por: Trinkley, Katy E., et al.
Publicado: (2015)

Diagnosing and managing acute heart failure in the emergency department
por: Kuo, Dick C., et al.
Publicado: (2015)

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids
por: Laugsand, Eivor A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d7b67ct1h22upjnii53gh7jc45